Price-driven growth masks margin compression, Ecosis ramp delayed
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Ecosis ₹80–90 Cr EBITDA target implicitly shelved (now 'EBITDA-positive'); PFI ₹150–200 Cr FY27 deferred to FY28. Brownfield on track (67% commissioned).
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong revenue growth (+21.2% YoY) is price-led, masking 8.3% volume decline and margin compression (EBITDA +2.4% YoY). Ecosis ramp behind schedule; commercialization uncertain until Q1 FY28. Long-term capex (Brownfield +Ecosis +2 new plants) is credible with FTA tailwinds, but near-term earnings pressure and execution risk argue for a wait-and-see stance.
₹1304.2 Cr
Revenue · +21.2% YoY₹52.2 Cr
Reported PAT · +9.8% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Sharp sequential improvement in financial performance
OVERSTATEDRevenue +13.9% QoQ to ₹1,304 Cr; but EBITDA +2.4% YoY only, PAT +9.8% YoY
Volume increased by 3.5% QoQ to 92,998 MT
METTranscript confirms 92,998 MT vs 89,872 in Q1; but YoY down 8.3% vs 101,390 in Q2 FY26
EBITDA per kg improved 13% to INR9.79 pk
METINR9.79 vs INR8.67 in Q1 = 12.9% improvement; accurate but driven by price, not volume
Ecosis 27K tons capacity will deliver ₹80–90 Cr EBITDA with 30%+ margins
MISSEcosis only 40–50% utilized in Q4 FY27; Q1 FY28 'gradually' increasing; 7–8K MT committed orders; now says 'EBITDA-positive' in Q4, no magnitude
PFI expansion will add ₹150–200 Cr revenue in FY27
OVERSTATEDManagement now states 'likely from early 2027'; deferred to FY28 realization
Earnings quality
What changed since the last call
Ecosis EBITDA guidance backed off
DowngradeQ1 call: ₹80–90 Cr EBITDA, 30%+ margins. Now: 'EBITDA-positive' in Q4 FY27 at 40–50% util., full ramp by Q1 FY28. Magnitude no longer disclosed.
PFI revenue contribution deferred
DowngradeQ1 call: ₹150–200 Cr in FY27. Now: 'likely from early 2027', implying FY28 realization. Push of ~6 months.
2-plant (1.5M TPD) timeline clarified
NeutralStill planned, now explicitly 'calendar 2029' (Q1 FY30 start). No change to scope, just clarity on start.
Core business margins under pressure
DowngradeNew flag: volume down 8.3% YoY; price inflation masking operational leverage loss. EBITDA +2.4% YoY vs +21.2% revenue shows cost inflation outpacing gains.
Capex timelines slipped weeks
NeutralBrownfield: machinery arrived late (after March 2026). Ecosis: pilot delayed, trials only starting mid-Nov. No capex cut, just slower ramp.
The Q&A
Analysts pressed hard on Ecosis volume commitments (7–8K MT vs 27K capacity), Ecosis EBITDA target (MGT backed off), margin drivers, and CapEx execution. Management held firm on long-term plans but was defensive/hedging on near-term earnings. No clear avoidance; tone was cautious but transparent about challenges.
Ecosis MOUs and volume — Surya Narayan Nayak, Sunidhi Securities
PartialMOUs with Decathlon, A&E, H&M; total committed ~7–8K MT. Polymerization trials started mid-Nov; quality yet to be established. Major commitment will come only post-plant audit.
Ecosis commercialization timeline — Surya Narayan Nayak, Sunidhi Securities
AnsweredQ4 FY27 capacity utilization ~40–50%; Q1 FY28 'gradually increase' to full. Orders expected by end of December at latest.
Recycled polyester pricing — Surya Narayan Nayak, Sunidhi Securities
AnsweredRecycled is NOT a premium over virgin. Pricing: INR130–140/kg recycled chip; INR30–35/kg margin on chip front.
Ecosis customer ramp and risk — Niraj Mansingka, White Pine Investment
AnsweredInitially MOUs for framework; now brands want volume commitments. 23 brands in talks. With H&M, approval just received. Major commitment comes post-audit; then immediately orders and supply ID codes. 6-month demand forecast already from Decathlon.
Ecosis customer identity — Niraj Mansingka, White Pine Investment
AnsweredDecathlon (China sourced before, wants Ecosis as exclusive co-brand). A&E (exclusive, final testing by mid-Dec). H&M (approval just received, seeks India supply). 2 Swedish suppliers also starting deliveries Dec. Largest are Decathlon, IKEA, H&M, A&E.
Volume commitment sustainability — Niraj Mansingka, White Pine Investment
PartialThese customers are market leaders, top 1–2 in categories. Bare minimums are baseline. If next 6 months go well, volumes 'go up exponentially.' Demand can grow seasonally (spring/summer peaks).
Brownfield commissioning — Surya Narayan Nayak, Sunidhi Securities
Answered2/3 commissioned (67%); FDY lines by Nov 23–25. By Jan, expecting full capacity. Incremental EBITDA from Brownfield: INR60–65 Cr (from INR91 current baseline).
FY28 profitability and double-digit EBITDA margins — Nirali, Unique PMS
PartialRaw material supply (GAIL, Indian Oil PTA plants starting) will help. FTA duty benefits (EU, UK, NZ) also kicking in. Core business: INR10–12/kg EBITDA per kg possible. With Ecosis, Brownfield, new projects, aggregate will improve; exceeding INR90 Cr EBITDA is likely but not guaranteed.
Demand outlook and capacity scaling — Nirali, Unique PMS
PartialSeasonality applies; demand-dependent. Currently 23 brands in talks. Assuming performance holds, 6-month forward visibility good. Volumes 'realistically' scale 6-month basis; market situation dependent.
Ecosis capex and profitability — Debarshi Deb, Inved
PartialQ4 FY27 EBITDA-positive (40–50% util.); Q1 FY28 improving. Exact timeline on cash positive TBD, but 'feasible within reasonable timeframe.'
Ecosis revenue and margin contribution to FY28 — Debarshi Deb, Inved
DodgedINR200 Cr revenue target mentioned (at Q3 guidance); EBITDA margins 'around 30%' (from earlier call). With both India and export mix.
Volume decline and demand pressure — Shikha Kapoor, Sprout Research
PartialYes, volume pressure due to price volatility and buying caution. Market is cautious when prices spike; defers purchases. As prices stabilize, demand should return. Volume normalized at ~93K MT (almost 95% utilization).
Brownfield ramp and deferral risk — Shikha Kapoor, Sprout Research
Answered2/3 commissioned; balance by Nov 23–25. Running lines. Commissioning is on, no major risk now.
Recycled chip pricing and margin — Shikha Kapoor, Sprout Research
AnsweredRecycled: conversion cost INR30–35/kg. Virgin polyester: different margin structure. Virgin chip INR110–120/kg base; recycled around INR130–140 (not a true premium, different process). Margins vary.
Capex financing and debt — Shikha Kapoor, Sprout Research
AnsweredINR230 Cr total ECB for Brownfield/Ecosis machinery. INR140 Cr new I-think INR80 Cr old ECB. INR82 Cr working capital debt. Forex: NO hedging long-term; short-term via LC 90-day hedging. Euro fell INR112 → INR104; opportunistic gains.
Skilled labor and project execution — Akhilesh Rawat, Vedanta Vision
AnsweredInitially labor shortage (migration due to war/monsoon). Now normalized; sufficient labor available. Installation on track.
Capex advantage vs global recyclers — Akhilesh Rawat, Vedanta Vision
AnsweredTech: proprietary glycolysis method built in-house over 7 years. Capex: INR2–4 per ton vs others' INR4–5+. Operational cost competitive. Tech + customer lock-in (early movers) + brand approval drive advantage.
Vietnam Ecosis expansion — Akhilesh Rawat, Vedanta Vision
PartialVietnam is successfully commissioned; in talks for second plant. Feedstock: Vietnam is under-organized but has supply. Research ongoing; no anticipated shortage for 150K TPD plant.
Bangladesh competition and FTA impact — Akhilesh Rawat, Vedanta Vision
AnsweredIndia-EU FTA huge (₹280B textile imports, 10–12% duty benefit). Bangladesh facing custom-duty disadvantage. India will gain competitive edge as buyers review sourcing. Long-term structural benefit for Indian exporters.
FY28 revenue guidance for Brownfield — Akhilesh Rawat, Vedanta Vision
DodgedCannot specify FY28 total; core business stable, Brownfield adds incrementally, Ecosis ramps, PFI from early 2027. By FY28, INR400 Cr revenue likely (conservative estimate).
Guidance
FY28 ₹400+ Cr revenue target (conservative; with Brownfield + Ecosis + PFI ramp)
MediumAnalyst Nirali notes ~INR200 Cr Ecosis revenue potential; Brownfield incremental; PFI from early 2027. No single quantified FY28 guidance issued.
Core business INR10–12/kg EBITDA per kg possible in FY28
MediumWith PTA supply and FTA benefits; vs current INR9.79/kg. Ecosis 30%+ EBITDA margins still targeted but timeline pushed to full ramp Q1 FY28.
Ecosis EBITDA-positive in Q4 FY27; full ramp to 30%+ margins by Q1 FY28
LowManagement now hedges: 'EBITDA-positive' at 40–50% utilization in Q4 FY27; exact magnitude not disclosed. 30%+ target from Q1 call now seen as stretch given 7–8K MT commitments.
INR690 Cr capex 95% done; completion by mid-FY28
HighBrownfield INR235 Cr done; Ecosis machinery ~95% installed (machinery delays resolved). 2 new plants (150K TPD each) for calendar 2029.
Risks the call surfaced
Margin compression in core
HighVolume down 8.3% YoY despite 21.2% price growth; EBITDA +2.4% YoY only. Cost inflation (raw materials, logistics) outpacing price realization.
Ecosis commercialization
HighEcosis machinery installed but only 7–8K MT commitments vs 27K TPD capacity; polymerization trials only started mid-Nov; Q4 FY27 utilization expected at 40–50% only. Original ₹80–90 Cr EBITDA target no longer stated.
Capex execution risk
MediumBrownfield machinery delayed (arriving after March 2026); Ecosis trials started later than planned. Commissioning timelines slipped by weeks. INR230 Cr ECB outstanding.
Volume pressure and demand uncertainty
MediumVolumes declined 8.3% YoY as buyers delayed purchases during price volatility. If crude-oil prices spike again, demand may remain subdued despite Brownfield/Ecosis coming online.
Customer concentration
MediumEcosis: Decathlon, A&E, H&M, IKEA are early movers; loss of any could impact ~20%+ of Ecosis revenue once ramps. Core business customer list not disclosed.
Management
Score 7/10. Transparent on challenges (price-driven growth, volume decline, capex delays) but hedging on future earnings targets. No formal guidance cut stated, but backing away from Ecosis ₹80–90 Cr EBITDA target. Some evasion on competitor capex and exact FY28 margin targets. Brownfield 67% commissioned, on schedule for Nov 25 target. Ecosis machinery ~95% installed but trials started late (mid-Nov vs expected earlier). Capex 95% done vs ₹690 Cr budget; broad tracking but weeks behind. Prior guidance on Ecosis and PFI partially missed or deferred.
1 · Nov 24–Dec 10, 2026
Brownfield Dahej expansion: POY extruders live, FDY lines commissioned
2 · Dec 2026
Ecosis first commercial batch; polymerization trials; Decathlon/A&E/H&M audits; order placement expected
3 · Q4 FY27
Ecosis EBITDA-positive target; Brownfield full utilization; volume momentum test
Long-term capex (Brownfield +Ecosis +2 new plants) is credible with FTA tailwinds, but near-term earnings pressure and execution risk argue for a wait-and-see stance.
Informational and educational content only. Not investment advice.